Community Insights-Chronic Pain

Transcription

1 Community Insights-Chronic Pain June 2018

2 Insights Table of Contents About the Community Primary Conditions Co-Morbidities Product Preference & Source Product Effectiveness Concurrent Therapies Community Feedback 2

3 Community Our community* is comprised of patients from around the world who voluntarily provide us with experiential information related to their condition, product preferences, uses and effectiveness. ValidCare applies technology and machine learning to offer Insights as a Service to power: Product & Market Intelligence Clinical Research & Remote Care Direct-to-Patient education and product information A Snapshot of Our Community *1000 s of patients in 20 countries. What can you learn from our community? 3

4 Patient Primary Conditions #1 6 Major Conditions Reported 20+ sub-conditions Age Range from Mean Median- 41 Sex Female-52.4% Male-47.6% Focus product development and messaging on top reported conditions Caregivers are key constituents for youth and elderly Adoption of app-based journaling is strong from baby-boomer through millennial generation 80% of patients fall into 3 categories 4

5 Patient Secondary Conditions 80% report a second condition 61% report a third condition 42% report a fourth condition Many patients have more than one type of chronic pain Need condition specific research One patient may need more than one product Suppliers need to deliver clear product education, messaging and branding Chronic pain patients are complex with multiple conditions 5

6 Patient Product Preference 50%+ use Flower and Topicals 74% use products with THC & 26% with CBD only Source of Products 76% Dispensary 8% Provider 16% Home grown Without Direct-to-Patient communication, dispensaries play a large role in product selection Marketing powered by patient data helps match effective products to conditions What factors influence product recommendation and selection? 6

7 Patient Product Effectiveness 74% of users report THC products deliver a neutral to positive effect 50% of patients report neutral to positive effect with CBD only While only 5% use Capsules, 100% reported effectiveness despite CBD Only formulation. Topicals are 2 nd highest use, but least effective Brand loyalty and credibility is at stake for those recommending topicals for chronic pain Capsule, vape and tincture may rival flower at scale. Flower & Topical are used most often, but reported less effective 7

8 Patient Concurrent Therapies Patients use traditional and non-traditional therapies in search of relief 38% of chronic pain patients use prescription medications plus another form of treatment Those using relaxation techniques and acupuncture tend to use less Rx products Chronic pain patients are in search of the right combination of products and treatments Branding opportunities with providers of alternative therapies Convergence of canna-based products and Eastern medicine techniques Complementary therapy may enhance product effectiveness 8

9 Community Feedback 90% want to share product experiences with suppliers and other patients 83% want to receive education and product information from suppliers 93% want to compare their experiences 89% want to participate in product research First mover advantage exists for suppliers who engage condition specific patient communities Real-time, secure communication with patients can accelerate product development Branded suppliers can build new, trusted patient relationships and brand loyalty Register receipts are un-reliable predictor of product efficacy and patient satisfaction Patients are eager to share & learn 9

10 Join the Community These Sample Insights illuminate patient experience with cannabis and CBD products over 12 months for the management of chronic pain. The Insights, while detailed, are just a sample of the information available as part of a membership subscription. For more information contact us at: info@validcare.com 10